For Authority Magazine’s series on technology making a positive social impact, Yitzi Weiner speaks with Helio founder and chairman Dr. Shu Li about resilience, reinvention, and a lifelong mission to detect cancer early.
For Authority Magazine’s series on technology making a positive social impact, Yitzi Weiner spoke with Dr. Shu Li, founder and chairman of Helio Genomics. A veteran technology executive with a Harvard doctorate and a long career across the semiconductor industry, Dr. Li now focuses on blood-based tests designed to catch cancer early, when it is most treatable. In the conversation, he reflects on resilience, reinvention, and the personal history behind his mission.
Across the conversation, Dr. Li traces an extraordinary personal journey — from a childhood marked by hardship to doctoral study at Harvard and senior leadership roles across the technology industry — and explains what later drew him to early cancer detection.
He talks through the traits he credits for his success, the family health history that shaped his focus, and his vision for making cancer a more survivable disease through simple, blood-based testing.
Read the full interview on Authority Magazine below.
View source version on medium.com.